SPONSOR
Arrowhead Pharmaceuticals
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1, Phase 2, Phase 3
Arrowhead Pharmaceuticals is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Asthma, Obesity, Diabetes Mellitus, Type 2, Homozygous Familial Hypercholesterolemia.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Arrowhead Pharmaceuticals
How many clinical trials has Arrowhead Pharmaceuticals sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Arrowhead Pharmaceuticals, of which 3 are actively recruiting participants. These trials cover conditions including Asthma, Obesity, Diabetes Mellitus, Type 2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Arrowhead Pharmaceuticals research focus on?
Arrowhead Pharmaceuticals clinical trials span Asthma, Obesity, Diabetes Mellitus, Type 2, Homozygous Familial Hypercholesterolemia. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Arrowhead Pharmaceuticals clinical trial?
To participate in a Arrowhead Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Arrowhead Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Arrowhead Pharmaceuticals
NCT07241546 Phase 2
Recruiting
Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
Asthma
NCT06937203 Phase 1, Phase 2
Recruiting
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
NCT07037771 Phase 3
Recruiting
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
Homozygous Familial Hypercholesterolemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology